Andreas Wildi

Andreas Wildi
Office:
Christoffelgasse 6
PO Box
3001
City:
Berne
State:
Berne
Country:
Switzerland
Tel:
+41 58 658 29 15

Biographies:

Who's Who Legal Switzerland - Life Sciences

Andreas Wildi, born in 1972, is a medical doctor and an attorney at law. He consults and represents Dow Jones and Nasdaq-listed multinational companies as well as mid-cap and small-cap enterprises in the life sciences sector. He mainly focuses on Swiss and international reimbursement and pricing law of pharmaceuticals and other therapeutic products. Regulatory issues of pharmaceuticals, medical devices, special nutrition, cosmetics, genetic testing, stem cell and blood products are his further key areas of practice.

Andreas Wildi studied medicine at the University of Zurich and graduated as medical doctor (MD). Working part-time in a hospital and a GP practice, and on international rescue missions, he completed his law degree at the University of St Gallen HSG (MLaw). Before passing the Bar exam, he gained his first professional legal experience as clerk with the Cantonal Court of Schaffhausen and with a recognised business law firm in Zurich. From his first position as an attorney at law in a large Zurich business law firm, Andreas Wildi was asked to work for the Swiss government, where he led the pharmaceutical reimbursement and pricing unit in the Federal Office of Public Health. Thereafter, Andreas Wildi broadened his market access expertise internationally, as EMEA market access law director for Janssen Pharmaceuticals (Johnson & Johnson). Since 2012, he has built up his legal practice in a large, well-regarded Zurich business law firm. In 2015, Walder Wyss elected Andreas Wildi as their partner.

Andreas Wildi works in German, French and English. He is admitted to all Swiss Courts.

With 200 lawyers, Walder Wyss is one of the most successful and fastest-growing Swiss commercial law firms, with offices in Zurich, Geneva, Basel, Berne, Lausanne and Lugano. They specialise in corporate and commercial law, banking and finance, intellectual property and competition law, dispute resolution and tax law. Their clients include national and international companies, publicly held corporations and family businesses as well as public law institutions and private clients.

WWL says: Andreas Wildi is a go-to individual for regulatory matters in the space, with sources lauding his “excellent experience from his time spent working on pricing within the pharmaceuticals industry”.

This biography is an extract from Who's Who Legal: Switzerland which can be purchased from our Shop.

Who's Who Legal Life Sciences: Regulatory

Andreas Wildi, born in 1972, is a medical doctor and an attorney at law. He consults and represents Dow Jones and Nasdaq-listed multinational companies, as well as mid-cap and small-cap enterprises in the life sciences sector. He mainly focuses on Swiss and international reimbursement and pricing law of pharmaceuticals and other therapeutic products. Regulatory issues of pharmaceuticals, medical devices, special nutrition, cosmetics, genetic testing, stem cell and blood products are his further key areas of practice.

Andreas Wildi studied medicine at the University of Zurich and graduated as medical doctor (MD). Working part-time in a hospital and a GP practice, and on international rescue missions, he completed his law degree at the University of St Gallen HSG (MLaw). Before passing the Bar exam, he gained his first professional legal experience as clerk with the Cantonal Court of Schaffhausen and with a recognised business law firm in Zurich. From his first position as an attorney at law in a large Zurich business law firm, Andreas Wildi was asked to work for the Swiss government, where he led the pharmaceutical reimbursement and pricing unit in the Federal Office of Public Health. Thereafter, Andreas Wildi broadened his market access expertise internationally, as EMEA market access law director for Janssen Pharmaceuticals (Johnson & Johnson). Since 2012, he has built up his legal practice in a large, well-regarded Zurich business law firm. In 2015, Walder Wyss elected Andreas Wildi as their partner. He lectures in pharmaceutical law at the University of Lucerne.

Andreas Wildi works in German, French and English. He is admitted to all Swiss courts.

With 200 lawyers, Walder Wyss is one of the most successful and fastest growing Swiss commercial law firms, with offices in Zurich, Geneva, Basel, Berne, Lausanne and Lugano. They specialise in corporate and commercial law, banking and finance, intellectual property and competition law, dispute resolution and tax law. Their clients include national and international companies, publicly held corporations and family businesses as well as public law institutions and private clients.

WWL says: Andreas Wildi is a distinguished figure in the space who draws plaudits for his top-level experience on pharmaceutical and medical device matters.

This biography is an extract from Who's Who Legal: Life Sciences which can be purchased from our Shop.

Follow us on LinkedIn

Practice Areas

Firms

Browse Firms

Search Firms

The Who's Who Legal 100

Awards

News & Features

Special Reports

Events

Shop

About Us

It is not possible to buy entry into any Who's Who Legal publication

Nominees have been selected based upon comprehensive, independent survey work with both general counsel and private practice lawyers worldwide. Only specialists who have met independent international research criteria are listed.

Copyright © 2019 Law Business Research Ltd. All rights reserved. | http://www.lbresearch.com

87 Lancaster Road, London, W11 1QQ, UK | Tel: +44 20 7908 1180 / Fax: +44 207 229 6910

http://www.whoswholegal.com | editorial@whoswholegal.com

Law Business Research Ltd

87 Lancaster Road, London
W11 1QQ, UK